Wikidata

(Q34155712)

English

Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712).

scientific article

In more languages

Statements

title
Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712). (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
12393429
retrieved
31 July 2017
author name string
Bercedis L Peterson
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
12393429
retrieved
31 July 2017
Vicki A Morrison
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
12393429
retrieved
31 July 2017
Kathleen Park
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
12393429
retrieved
31 July 2017
Robert Jacobson
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
12393429
retrieved
31 July 2017
Charles A Schiffer
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
12393429
retrieved
31 July 2017
Richard A Larson
series ordinal
10
1 reference
stated in
Europe PubMed Central
PubMed ID
12393429
retrieved
31 July 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q34155712&oldid=1766514529"